PMC:7199903 / 92-243
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T2","span":{"begin":118,"end":125},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"Vaccine development for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is focused on the trimeric spike protein that initiates infection."}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T3","span":{"begin":24,"end":71},"obj":"Disease"},{"id":"T4","span":{"begin":24,"end":57},"obj":"Disease"},{"id":"T5","span":{"begin":73,"end":81},"obj":"Disease"},{"id":"T6","span":{"begin":141,"end":150},"obj":"Disease"}],"attributes":[{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Vaccine development for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is focused on the trimeric spike protein that initiates infection."}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1","span":{"begin":85,"end":95},"obj":"http://purl.obolibrary.org/obo/CLO_0009985"}],"text":"Vaccine development for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is focused on the trimeric spike protein that initiates infection."}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T2","span":{"begin":118,"end":125},"obj":"Chemical"}],"attributes":[{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"Vaccine development for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is focused on the trimeric spike protein that initiates infection."}
LitCovid-sample-PD-IDO
{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T2","span":{"begin":141,"end":150},"obj":"http://purl.obolibrary.org/obo/IDO_0000586"}],"text":"Vaccine development for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is focused on the trimeric spike protein that initiates infection."}
LitCovid-sample-Enju
{"project":"LitCovid-sample-Enju","denotations":[{"id":"T14","span":{"begin":20,"end":23},"obj":"IN"},{"id":"T15","span":{"begin":24,"end":30},"obj":"JJ"},{"id":"T16","span":{"begin":31,"end":36},"obj":"JJ"},{"id":"T17","span":{"begin":37,"end":48},"obj":"JJ"},{"id":"T18","span":{"begin":49,"end":57},"obj":"NN"},{"id":"T19","span":{"begin":58,"end":69},"obj":"NN"},{"id":"T20","span":{"begin":70,"end":71},"obj":"CD"},{"id":"T21","span":{"begin":72,"end":73},"obj":"-LRB-"},{"id":"T12","span":{"begin":0,"end":7},"obj":"NN"},{"id":"T13","span":{"begin":8,"end":19},"obj":"NN"},{"id":"T22","span":{"begin":73,"end":83},"obj":"NN"},{"id":"T23","span":{"begin":83,"end":84},"obj":"-RRB-"},{"id":"T24","span":{"begin":85,"end":87},"obj":"VBZ"},{"id":"T25","span":{"begin":88,"end":95},"obj":"VBN"},{"id":"T26","span":{"begin":96,"end":98},"obj":"IN"},{"id":"T27","span":{"begin":99,"end":102},"obj":"DT"},{"id":"T28","span":{"begin":103,"end":111},"obj":"JJ"},{"id":"T29","span":{"begin":112,"end":117},"obj":"NN"},{"id":"T30","span":{"begin":118,"end":125},"obj":"NN"},{"id":"T31","span":{"begin":126,"end":130},"obj":"WDT"},{"id":"T32","span":{"begin":131,"end":140},"obj":"VBZ"},{"id":"T33","span":{"begin":141,"end":150},"obj":"NN"}],"relations":[{"id":"R21","pred":"arg1Of","subj":"T13","obj":"T24"},{"id":"R22","pred":"arg2Of","subj":"T25","obj":"T24"},{"id":"R23","pred":"arg2Of","subj":"T13","obj":"T25"},{"id":"R24","pred":"arg1Of","subj":"T25","obj":"T26"},{"id":"R25","pred":"arg2Of","subj":"T30","obj":"T26"},{"id":"R26","pred":"arg1Of","subj":"T30","obj":"T27"},{"id":"R27","pred":"arg1Of","subj":"T30","obj":"T28"},{"id":"R28","pred":"arg1Of","subj":"T30","obj":"T29"},{"id":"R29","pred":"arg1Of","subj":"T30","obj":"T31"},{"id":"R10","pred":"arg1Of","subj":"T13","obj":"T12"},{"id":"R11","pred":"arg1Of","subj":"T13","obj":"T14"},{"id":"R12","pred":"arg2Of","subj":"T19","obj":"T14"},{"id":"R13","pred":"arg1Of","subj":"T19","obj":"T15"},{"id":"R14","pred":"arg1Of","subj":"T19","obj":"T16"},{"id":"R15","pred":"arg1Of","subj":"T19","obj":"T17"},{"id":"R16","pred":"arg1Of","subj":"T19","obj":"T18"},{"id":"R17","pred":"arg1Of","subj":"T19","obj":"T20"},{"id":"R18","pred":"arg1Of","subj":"T19","obj":"T21"},{"id":"R19","pred":"arg2Of","subj":"T22","obj":"T21"},{"id":"R20","pred":"arg3Of","subj":"T23","obj":"T21"},{"id":"R30","pred":"arg1Of","subj":"T30","obj":"T32"},{"id":"R31","pred":"arg2Of","subj":"T33","obj":"T32"}],"text":"Vaccine development for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is focused on the trimeric spike protein that initiates infection."}
LitCovid-sample-PD-FMA
{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T2","span":{"begin":118,"end":125},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"Vaccine development for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is focused on the trimeric spike protein that initiates infection."}
LitCovid-sample-CHEBI
{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T2","span":{"begin":118,"end":125},"obj":"Chemical"}],"attributes":[{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"Vaccine development for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is focused on the trimeric spike protein that initiates infection."}
LitCovid-sample-PD-NCBITaxon
{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T3","span":{"begin":24,"end":71},"obj":"Species"},{"id":"T4","span":{"begin":73,"end":83},"obj":"Species"}],"attributes":[{"id":"A3","pred":"ncbi_taxonomy_id","subj":"T3","obj":"NCBItxid:2697049"},{"id":"A4","pred":"ncbi_taxonomy_id","subj":"T4","obj":"NCBItxid:2697049"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"Vaccine development for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is focused on the trimeric spike protein that initiates infection."}
LitCovid-sample-sentences
{"project":"LitCovid-sample-sentences","denotations":[{"id":"T3","span":{"begin":0,"end":151},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Vaccine development for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is focused on the trimeric spike protein that initiates infection."}
LitCovid-sample-PD-MONDO
{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T3","span":{"begin":24,"end":71},"obj":"Disease"},{"id":"T4","span":{"begin":73,"end":83},"obj":"Disease"},{"id":"T5","span":{"begin":141,"end":150},"obj":"Disease"}],"attributes":[{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Vaccine development for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is focused on the trimeric spike protein that initiates infection."}
LitCovid-sample-Pubtator
{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"17","span":{"begin":112,"end":117},"obj":"Gene"},{"id":"19","span":{"begin":24,"end":71},"obj":"Species"},{"id":"20","span":{"begin":73,"end":83},"obj":"Species"},{"id":"25","span":{"begin":141,"end":150},"obj":"Disease"}],"attributes":[{"id":"A17","pred":"pubann:denotes","subj":"17","obj":"Gene:43740568"},{"id":"A19","pred":"pubann:denotes","subj":"19","obj":"Tax:2697049"},{"id":"A20","pred":"pubann:denotes","subj":"20","obj":"Tax:2697049"},{"id":"A25","pred":"pubann:denotes","subj":"25","obj":"MESH:D007239"}],"text":"Vaccine development for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is focused on the trimeric spike protein that initiates infection."}
LitCovid-sample-UniProt
{"project":"LitCovid-sample-UniProt","denotations":[{"id":"T2","span":{"begin":112,"end":125},"obj":"Protein"}],"attributes":[{"id":"A2","pred":"uniprot_id","subj":"T2","obj":"https://www.uniprot.org/uniprot/P31340"}],"text":"Vaccine development for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is focused on the trimeric spike protein that initiates infection."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T3","span":{"begin":0,"end":151},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Vaccine development for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is focused on the trimeric spike protein that initiates infection."}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"17","span":{"begin":112,"end":117},"obj":"Gene"},{"id":"19","span":{"begin":24,"end":71},"obj":"Species"},{"id":"20","span":{"begin":73,"end":83},"obj":"Species"},{"id":"25","span":{"begin":141,"end":150},"obj":"Disease"}],"attributes":[{"id":"A17","pred":"tao:has_database_id","subj":"17","obj":"Gene:43740568"},{"id":"A19","pred":"tao:has_database_id","subj":"19","obj":"Tax:2697049"},{"id":"A20","pred":"tao:has_database_id","subj":"20","obj":"Tax:2697049"},{"id":"A25","pred":"tao:has_database_id","subj":"25","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Vaccine development for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is focused on the trimeric spike protein that initiates infection."}